Federal Reserve Economic Data: Your trusted data source since 1991

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities and Stockholders' Equity (QFR328385USNO)

Observation:

Q4 2023: 1,797,347 (+ more)   Updated: Mar 18, 2024 9:09 AM CDT
Q4 2023:  1,797,347  
Q3 2023:  1,742,769  
Q2 2023:  1,742,622  
Q1 2023:  1,721,723  
Q4 2022:  1,695,947  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities and Stockholders' Equity [QFR328385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFR328385USNO, April 9, 2024.

RELATED DATA AND CONTENT


Subscribe to the FRED newsletter


Follow us

Back to Top
Top